Xenon Attenuates Cerebral Damage after Ischemia in Pigs

@article{Schmidt2005XenonAC,
  title={Xenon Attenuates Cerebral Damage after Ischemia in Pigs},
  author={Michael R. Schmidt and T. Marx and Egon Gl{\"o}ggl and H. Reinelt and U. Schirmer},
  journal={Anesthesiology},
  year={2005},
  volume={102},
  pages={929-936}
}
Background: Cerebral blood flow may be compromised in a variety of anesthetic procedures, and ischemic cerebral complications represent the leading cause of morbidity after cardiac operations. With the growing importance of neuroprotective strategies, the current study was designed to determine whether xenon would attenuate cardiac arrest–induced brain injury in pigs. Methods: Twenty-four pigs (aged 12–16 weeks) were investigated in a randomized design. General hemodynamics, intracranial… Expand
Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs*
TLDR
These results demonstrate that even a short exposure to xenon during induction of mild therapeutic hypothermia results in significant improvements in functional recovery and ameliorated myocardial dysfunction. Expand
Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs*
TLDR
Xenon conferred neurohistopathologic protection, translating in transiently improved functional outcome after cardiopulmonary resuscitation in xenon-treated animals, resulting in improved neurocognitive and neurologic function on day 1 to 3 after cardiac arrest. Expand
Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats.
TLDR
This study demonstrates that a single 1 h application of 70% argon significantly reduced histopathological damage of the neocortex and hippocampus, associated with a marked improvement in functional neurological recovery. Expand
Xenon Neuroprotection in Experimental Stroke: Interactions with Hypothermia and Intracerebral Hemorrhage
TLDR
Xenon improved focal ischemic outcome at 7, but not 28 days postischemia, and combined with subtherapeutic hypothermia produced sustained recovery benefit, which may have potential for clinical stroke therapy under carefully defined conditions. Expand
Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage
TLDR
This study demonstrates that a 1-h application of argon provided a significant reduction in histopathological damage, associated with a marked improvement in functional neurologic recovery even when treatment was delayed for 3 h, highly significant with regard to clinical situations, where argon treatment cannot be provided timely. Expand
Inhaled xenon neuro- and cardioprotection following out-of-hospital cardiac arrest. A randomized, controlled trial
TLDR
Combining inhaled xenon and therapeutic hypothermia in cardiac arrest patients was safe and feasible and significantly attenuated brain white matter injury illustrated with higher FA-values, translating to significant neuroand cardioprotection against ongoing ischaemia-reperfusion injury by xenon inhalation combined with hypotheria. Expand
Influence of argon on temperature modulation and neurological outcome in hypothermia treated rats following cardiac arrest.
TLDR
It is demonstrated that argon augmented MTH does not improve functional recovery after CA in rats, but may even worsen neurologic function in this model. Expand
Delayed post-ischaemic administration of xenon reduces brain damage in a rat model of global ischaemia
TLDR
The data indicate that N2O and xenon administration is neuroprotective 1 hour after bilateral common carotid artery occlusion, and this findings provide valuable evidence on the beneficial role of N 2O and Xenon in global cerebral injury. Expand
The future is now: neuroprotection during cardiopulmonary resuscitation
TLDR
Multiple promising neuroprotective therapies are being developed in animal models of cardiac arrest, and are in early stages of human trials that have the potential to be bundled together to improve rates of favorable neurological survival after cardiac arrest. Expand
Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
TLDR
Argon showed a neuroprotective effect in both in vitro models of oxygen-glucose deprivation and traumatic brain injury, and this results justify further in vivo animal research. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
Xenon Attenuates Cardiopulmonary Bypass–induced Neurologic and Neurocognitive Dysfunction in the Rat
TLDR
It is indicated that CPB-induced neurologic and neurocognitive dysfunction can be attenuated by the administration of xenon, potentially related to its neuroprotective effect via N-methyl-d-aspartate receptor antagonism. Expand
Cerebral and regional organ perfusion in pigs during xenon anaesthesia
TLDR
It is concluded that xenon should be used with caution in clinical situations associated with pathological increases in intracranial pressure, e.g. neurosurgical procedures, head injury, cerebral mass lesions or stroke. Expand
Relative Neuroprotective Effects of Dizocilpine and Isoflurane During Focal Cerebral Ischemia in the Rat
TLDR
The hypothesis that NMDA receptor activation is injurious during focal ischemia and that amelioration of focal ischemic brain damage by N-methyl-D-aspartate receptor antagonists persists under normothermic conditions is supported. Expand
Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function.
TLDR
Inhalation of 70% xenon had no effect on haemodynamics in closed-chest rabbits, as measured by echocardiography, showing that xenon has only minimal negative inotropic effects in rabbits with LV dysfunction after coronary artery ligation. Expand
Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators.
TLDR
Adverse cerebral outcomes after coronary bypass surgery are relatively common and serious; they are associated with substantial increases in mortality, length of hospitalization, and use of intermediate- or long-term care facilities. Expand
Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery
TLDR
The haemodynamic profile and recovery characteristics of xenon compared with propofol sedation in postoperative cardiac surgery patients are investigated, and a fully closed breathing system is evaluated to minimise xenon consumption. Expand
Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs.
TLDR
The relationship between the residual CBF and both oxygen metabolism and extraction is critical to the evolution of metabolic deficiency and lesion size after stroke. Expand
Multicenter Randomized Comparison of the Efficacy and Safety of Xenon and Isoflurane in Patients Undergoing Elective Surgery
TLDR
This first randomized controlled multicenter trial on the use of xenon as an inhalational anesthetic confirms that xenon in oxygen provides effective and safe anesthesia, with the advantage of a more rapid recovery when compared with anesthesia using isoflurane–nitrous oxide. Expand
Adverse Cerebral Outcomes after Coronary Bypass Surgery
TLDR
A multicenter study to determine the incidence and predictors of — and the use of resources associated with — perioperative adverse neurologic events, including cerebral injury, found patients with adverse cerebral outcomes had higher in-hospital mortality. Expand
Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration.
TLDR
Bedside intracerebral microdialysis monitoring of patients with subarachnoid hemorrhage and signs of delayed ischemia revealed dramatic changes in extracellular concentrations of glucose, lactate, and glycerol that could be directly correlated to the clinical status of the patients. Expand
...
1
2
3
4
5
...